Research & Data
CHPA strives to continually reinforce, define, and quantify the value of over-the-counter (OTC) medicines for consumers and the healthcare system. The following CHPA research initiatives and products highlight the meaningful ways that OTC medicines provide consumers access to trusted, affordable, empowering self-care options.
Research Reports
OTC Use Statistics
Consumer Medical Device Statistics
Market Research Companies
CHPA does not develop or track (over-the-counter) OTC medicine or dietary supplement product sales or market share data. The following companies provide selected marketing statistics:
- Competitive Promotion Report LLC, 770.565.0735, ext. 106 (both OTCs and dietary supplements)
- *Euromonitor, 312.922.1115, ext. 241 (both OTCs and dietary supplements)
- Hamacher Resource Group, 414.431.5301 (both OTCs and dietary supplements)
- *The Hartman Group, 425.452.0818 (dietary supplements)
- IMS Health, 484.567.6256 (both OTCs and dietary supplements)
- *Kline Management Consulting, 973.435.3446 (both OTC and dietary supplements)
- *Mintel International Group Ltd., 312.932.0400 (both OTC and dietary supplements)
- Nielsen, 856.321.2550 (both OTCs and dietary supplements)
- *Nutrition Business Journal, 619.295.7685, ext. 15 (dietary supplements)
- ORC International, 212.329.1001 (both OTCs and dietary supplements)
- Persuadable Research Corporation, 913.385.1700, ext. 302
- *Simon-Kucher & Partners, LLC, 617.407.4644 (both OTCs and dietary supplements)
- IRI, 973.903.5197 (both OTCs and dietary supplements)
*Not a CHPA Member